Magnesium alloy with adjustable degradation rate
US-2016022876-A1 · Jan 28, 2016 · US
US9593397B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9593397-B2 |
| Application number | US-201414203950-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2014 |
| Priority date | Mar 14, 2013 |
| Publication date | Mar 14, 2017 |
| Grant date | Mar 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An alloy and an implant having a three-dimensional structure based on such alloy. The alloy comprises a MgZnCa alloy containing nanosized precipitates being less noble than the Mg matrix alloy and having a Zn content ranging 0.1 wt. % Zn to 2 wt. % Zn and a calcium content ranging from 0.2 wt. % to 0.5 wt. %, and having less than 0.04 wt. % of one or more other elements with the remainder being Mg. For these micro-alloys, any second phase generated during the solidification process can be completely dissolved by a solution heat treatment. Finely dispersed nanosized precipitates can then be generated by a subsequent aging heat treatment step. These precipitates are used to “pin” the grain boundaries and to prevent the coarsening of the grain structure during further processing to achieve grain sizes below 5 μm.
Opening claim text (preview).
The invention claimed is: 1. A composition comprising: a MgZnCa alloy containing nanosized precipitates, the alloy having a Zn content ranging from 0.1 wt. % Zn to 2.0 wt. % Zn and a calcium content ranging from 0.2 wt. % Ca to 0.5 wt. % Ca, less than 0.04 wt. % of one or more other elements and with the remainder of the alloy being Mg, wherein the nanosized precipitates are less noble than the remainder Mg. 2. The composition of claim 1 , wherein the alloy contains less than 400 ppm of total other elements. 3. The composition of claim 2 , wherein the one or more other elements comprise Fe, Cu, Ni, Co, Si, Mn, Al, Zr, P or any combination thereof. 4. The composition of claim 1 , wherein the alloy is substantially free of microgalvanic elements. 5. The composition of claim 1 , wherein the nanosized precipitates that are less noble than the remainder Mg comprise (Mg,Zn) 2 Ca. 6. The composition of claim 1 , further comprising nanosized precipitates that are more noble than the Mg remainder wherein said precipitates comprise Mg 6 Zn 3 Ca 2 . 7. The composition of claim 1 , wherein the alloy has a grain size of less than 5 μm. 8. The composition of claim 1 , wherein the alloy has a yield strength of at least 180 MPa. 9. The composition of claim 1 , wherein the alloy has an ultimate tensile strength of at least 240 MPa. 10. The composition of claim 1 , wherein the alloy has at least 10% elongation at break. 11. An implant comprising the composition of claim 1 . 12. The implant of claim 11 , wherein the implant has an in vitro degradation rate of less than 0.5 mg/cm 2 day as measured in a simulated body fluid. 13. The implant of claim 11 , wherein the implant is an orthopedic implant. 14. The implant of claim 13 , wherein the orthopedic implant comprises a nail, a screw, a staple, a plate, a rod, a tack, a bolt, a bolt to lock and IM nail, an anchor, a dowel, a plug, a peg, a sleeve, a mesh, a transconnector, a nut, a shaped body, a spinal cage, a wire, a K-wire, a woven structure, a clamp, a splint, a scaffold, a foam, a honeycomb structure, or any combination thereof. 15. The implant of claim 11 , wherein the implant is a non-orthopedic implant. 16. The implant of claim 15 , wherein the non-orthopedic implant comprises a cardiovascular stent, a neuro stent, or a vertebroplasty stent. 17. The implant of claim 11 , wherein the implant has a lower degradation rate compared to implants made from a magnesium alloy containing microgalvanic elements. 18. A method of producing the composition of claim 1 , comprising the steps of: (a) casting a mixture containing (i) magnesium having a purity of at least 99.96 wt. % and having less than 0.04 wt. % of one or more other elements; (ii) from 0.1 wt. % to 2.0 wt. % zinc having a purity of at least 99.9 wt. %; and (iii) from 0.2 wt. % to 0.5 wt. % calcium metal having a purity of at least 99.9 wt. %, said casting being performed in an inert atmosphere and an inert reaction vessel; (b) solution heat treating of the cast alloy at two or more different temperatures wherein a first temperature is below an eutectic temperature of Mg—Zn and a second temperature is above an eutectic temperature of the ternary Mg—Zn—Ca system to thereby form a MgZnCa alloy containing from 0.1 wt. % Zn to 2 wt. % Zn, and a calcium content ranging from 0.2 wt. % Ca to 0.5 wt. % Ca, and having less than 0.04 wt. % of one or more other elements with the remainder being Mg; (c) age heat treating between 100° C. and 300° C. to create dispersed nanosized precipitates; and (d) extruding the alloy into a desired shape. 19. The method of claim 18 , further comprising the step of: second age heat treating of the shaped alloy to improve strength or ductility.
with zinc or cadmium as the next major constituent · CPC title
with aluminium as the next major constituent · CPC title
Metals or alloys · CPC title
Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces · CPC title
Materials at least partially resorbable by the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.